{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T11:37:47Z","timestamp":1794569867615,"version":"4.9.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T00:00:00Z","timestamp":1660694400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T00:00:00Z","timestamp":1660694400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The present study was supported by grants from Rete Oncologica del Piemonte e Valle d\u2019Aosta and Fondazione Cassa di Risparmio di Torino","award":["file number: 2021.0553)."],"award-info":[{"award-number":["file number: 2021.0553)."]}],"id":[{"id":"https:\/\/ror.org\/036wwq305","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006692","name":"Universit\u00e0 degli Studi di Torino","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006692","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The term uterine smooth muscle tumor of uncertain malignant potential (STUMP) indicates a rare, equivocal entity between benign leiomyomas and leiomyosarcomas. In the present study, we evaluated a comprehensive range of clinical, surgical, and pathological features in a large multicenter series of patients with STUMP to identify risk factors for recurrence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a retrospective study performed by collecting consecutive cases diagnosed between January 2000 and December 2020 in five tertiary centers. Associations between STUMP recurrence and clinicopathological characteristics as well as surgical treatment modality were investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Eighty-seven patients affected by STUMP were considered. Of them, 18 cases (20.7%) recurred: 11 as leiomyosarcoma (LMS) and 7 as STUMP. The mean time to recurrence was 79 months. We found that fragmentation\/morcellation, epithelioid features, high mitotic count, Ki-67 value &gt; 20%, progesterone receptor (PR) &lt; 83%, and p16 diffuse expression were associated with higher risk of recurrence and shorter recurrence-free survival (RFS). Furthermore, morcellation\/fragmentation and mitotic count remained independent risk factors for recurrence and shorter RFS after multivariate analysis, while the presence of epithelioid features was an independent risk factor for recurrence only.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results suggest that morcellation is associated with risk of recurrence and shorter RFS, thus it should be avoided if a STUMP is suspected preoperatively. Epithelioid features, high proliferation activity, low PR expression, and diffuse p16 expression are also unfavorable prognostic factors, so patients presenting these features should be closely followed up.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1245\/s10434-022-12353-y","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T10:05:17Z","timestamp":1660730717000},"page":"8302-8314","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Clinical and Histopathological Predictors of Recurrence in Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Multicenter Retrospective Cohort Study of Tertiary Centers"],"prefix":"10.1245","volume":"29","author":[{"given":"Fulvio","family":"Borella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Cosma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Ferraioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Ray-Coquard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Chopin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Meeus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Cockenpot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Valabrega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Scotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Turinetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Biglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Fuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorella","family":"Franchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailyn Mariela","family":"Vidal Urbinati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Pino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Bertschy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Preti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Benedetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Castellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Cassoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Bertero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,17]]},"reference":[{"issue":"7","key":"12353_CR1","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1097\/PAS.0b013e3181a02d1c","volume":"33","author":"PPC Ip","year":"2009","unstructured":"Ip PPC, Cheung ANY, Clement PB. Uterine smooth muscle tumors of uncertain malignant potential (STUMP): a clinicopathologic analysis of 16 cases. Am J Surg Pathol. 2009;33(7):992\u20131005. https:\/\/doi.org\/10.1097\/PAS.0b013e3181a02d1c.","journal-title":"Am J Surg Pathol."},{"issue":"3","key":"12353_CR2","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ygyno.2009.02.020","volume":"113","author":"SR Guntupalli","year":"2009","unstructured":"Guntupalli SR, Ramirez PT, Anderson ML, Milam MR, Bodurka DC, Malpica A. Uterine smooth muscle tumor of uncertain malignant potential: a retrospective analysis. Gynecol Oncol. 2009;113(3):324\u20136. https:\/\/doi.org\/10.1016\/j.ygyno.2009.02.020.","journal-title":"Gynecol Oncol."},{"issue":"8","key":"12353_CR3","doi-asserted-by":"crossref","first-page":"625","DOI":"10.47102\/annals-acadmedsg.V39N8p625","volume":"39","author":"JSY Ng","year":"2010","unstructured":"Ng JSY, Han A, Chew SH, Low J. A clinicopathologic study of uterine smooth muscle tumors of uncertain malignant potential (STUMP). Ann Acad Med Singap. 2010;39(8):625\u20138.","journal-title":"Ann Acad Med Singap."},{"issue":"6","key":"12353_CR4","first-page":"412","volume":"83","author":"A Da\u0144ska-Bidzi\u0144ska","year":"2012","unstructured":"Da\u0144ska-Bidzi\u0144ska A, Baku\u0142a-Zalewska E, Nasierowska-Guttmejer A, et al. Smooth muscle tumor of uncertain malignant potential (STUMP)\u2014clinico-pathomorphological analysis of the cases and literature review. Ginekol Pol. 2012;83(6):412\u20136.","journal-title":"Ginekol Pol."},{"issue":"11","key":"12353_CR5","first-page":"8136","volume":"7","author":"A Dall\u2019Asta","year":"2014","unstructured":"Dall\u2019Asta A, Gizzo S, Musar\u00f2 A, et al. Uterine smooth muscle tumors of uncertain malignant potential (STUMP): pathology, follow-up and recurrence. Int J Clin Exp Pathol. 2014;7(11):8136\u201342.","journal-title":"Int J Clin Exp Pathol."},{"issue":"3","key":"12353_CR6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.14740\/wjon1031w","volume":"8","author":"BH Bacanakgil","year":"2017","unstructured":"Bacanakgil BH, Deveci M, Karabuk E, Soyman Z. Uterine smooth muscle tumor of uncertain malignant potential: clinicopathologic-sonographic characteristics, follow-up and recurrence. World J Oncol. 2017;8(3):76\u201380. https:\/\/doi.org\/10.14740\/wjon1031w.","journal-title":"World J Oncol."},{"issue":"2","key":"12353_CR7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/IGC.0000000000001178","volume":"28","author":"D Basaran","year":"2018","unstructured":"Basaran D, Usubutun A, Salman MC, et al. The clinicopathological study of 21 cases with uterine smooth muscle tumors of uncertain malignant potential: centralized review can purify the diagnosis. Int J Gynecol Cancer. 2018;28(2):233\u201340. https:\/\/doi.org\/10.1097\/IGC.0000000000001178.","journal-title":"Int J Gynecol Cancer."},{"issue":"2","key":"12353_CR8","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/his.13515","volume":"73","author":"M Gupta","year":"2018","unstructured":"Gupta M, Laury AL, Nucci MR, Quade BJ. Predictors of adverse outcome in uterine smooth muscle tumours of uncertain malignant potential (STUMP): a clinicopathological analysis of 22 cases with a proposal for the inclusion of additional histological parameters. Histopathology. 2018;73(2):284\u201398. https:\/\/doi.org\/10.1111\/his.13515.","journal-title":"Histopathology."},{"issue":"4","key":"12353_CR9","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2019.30.e54","volume":"30","author":"H \u015eahin","year":"2019","unstructured":"\u015eahin H, Karatas F, Coban G, et al. Uterine smooth muscle tumor of uncertain malignant potential: fertility and clinical outcomes. J Gynecol Oncol. 2019;30(4):e54. https:\/\/doi.org\/10.3802\/jgo.2019.30.e54.","journal-title":"J Gynecol Oncol."},{"key":"12353_CR10","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3389\/fonc.2020.00647","volume":"10","author":"L Huo","year":"2020","unstructured":"Huo L, Wang D, Wang W, et al. Oncologic and reproductive outcomes of uterine smooth muscle tumor of uncertain malignant potential: a single center retrospective study of 67 cases. Front Oncol. 2020;10:647. https:\/\/doi.org\/10.3389\/fonc.2020.00647.","journal-title":"Front Oncol."},{"key":"12353_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ejogrb.2020.01.002","volume":"246","author":"JI Shim","year":"2020","unstructured":"Shim JI, Han AKW, Jeon HJ, et al. Clinical experience of uterine smooth muscle tumor of uncertain malignant potential in two gynecological centers: oncological and obstetrical aspects. Eur J Obstet Gynecol Reprod Biol. 2020;246:7\u201313. https:\/\/doi.org\/10.1016\/j.ejogrb.2020.01.002.","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"issue":"4","key":"12353_CR12","first-page":"818","volume":"13","author":"YY Zheng","year":"2020","unstructured":"Zheng YY, Liu XB, Mao YY, Lin MH. Smooth muscle tumor of uncertain malignant potential (STUMP): a clinicopathologic analysis of 26 cases. Int J Clin Exp Pathol. 2020;13(4):818\u201326.","journal-title":"Int J Clin Exp Pathol."},{"issue":"6","key":"12353_CR13","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/00000478-199406000-00001","volume":"18","author":"SW Bell","year":"1994","unstructured":"Bell SW, Kempson RL, Hendrickson MR. Problematic uterine smooth muscle neoplasms: A clinicopathologic study of 213 cases. Am J Surg Pathol. 1994;18(6):535\u201358.","journal-title":"Am J Surg Pathol."},{"key":"12353_CR14","unstructured":"Smooth muscle tumour of uncertain malignant potential of the uterine corpus. In WHO Classification of Tumours Editorial Board (Eds.), WHO Classification of Tumours, 5th Edition, Female Genital Tumours, p. 279\u2013280. Lyon: International Agency for Research on Cancer, 2020"},{"key":"12353_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ejogrb.2020.05.040","volume":"251","author":"I Cotrino","year":"2020","unstructured":"Cotrino I, Carosso A, Macchi C, et al. Ultrasound and clinical characteristics of uterine smooth muscle tumors of uncertain malignant potential (STUMPs). Eur J Obstet Gynecol Reprod Biol. 2020;251:167\u201372. https:\/\/doi.org\/10.1016\/j.ejogrb.2020.05.040.","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"issue":"3","key":"12353_CR16","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.ygyno.2019.07.002","volume":"154","author":"A Gadducci","year":"2019","unstructured":"Gadducci A, Zannoni GF. Uterine smooth muscle tumors of unknown malignant potential: a challenging question. Gynecol Oncol. 2019;154(3):631\u20137. https:\/\/doi.org\/10.1016\/j.ygyno.2019.07.002.","journal-title":"Gynecol Oncol."},{"issue":"7","key":"12353_CR17","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/j.1365-2559.2007.02699.x","volume":"50","author":"CJ O\u2019Neill","year":"2007","unstructured":"O\u2019Neill CJ, McBride HA, Connolly LE, McCluggage WG. Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential. Histopathology. 2007;50(7):851\u20138. https:\/\/doi.org\/10.1111\/j.1365-2559.2007.02699.x.","journal-title":"Histopathology."},{"issue":"3","key":"12353_CR18","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jmig.2011.12.025","volume":"19","author":"GA Vilos","year":"2012","unstructured":"Vilos GA, Marks J, Ettler HC, Vilos AG, Prefontaine M, Abu-Rafea B. Uterine smooth muscle tumors of uncertain malignant potential: diagnostic challenges and therapeutic dilemmas: Report of 2 cases and review of the literature. J Minim Invasive Gynecol. 2012;19(3):288\u201395. https:\/\/doi.org\/10.1016\/j.jmig.2011.12.025.","journal-title":"J Minim Invasive Gynecol."},{"issue":"4","key":"12353_CR19","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.jmig.2015.01.007","volume":"22","author":"EL Mowers","year":"2015","unstructured":"Mowers EL, Skinner B, McLean K, Reynolds RK. Effects of morcellation of uterine smooth muscle tumor of uncertain malignant potential and endometrial stromal sarcoma: case series and recommendations for clinical practice. J Minim Invasive Gynecol. 2015;22(4):601\u20136. https:\/\/doi.org\/10.1016\/j.jmig.2015.01.007.","journal-title":"J Minim Invasive Gynecol."},{"issue":"1","key":"12353_CR20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ygyno.2020.10.020","volume":"160","author":"S PedraNobre","year":"2021","unstructured":"PedraNobre S, Hensley ML, So M, et al. The impact of tumor fragmentation in patients with stage I uterine leiomyosarcoma on patterns of recurrence and oncologic outcome. Gynecol Oncol. 2021;160(1):99\u2013105. https:\/\/doi.org\/10.1016\/j.ygyno.2020.10.020.","journal-title":"Gynecol Oncol."},{"issue":"1","key":"12353_CR21","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ygyno.2016.11.002","volume":"144","author":"F Raspagliesi","year":"2017","unstructured":"Raspagliesi F, Maltese G, Bogani G, et al. Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: a retrospective MITO group study. Gynecol Oncol. 2017;144(1):90\u20135. https:\/\/doi.org\/10.1016\/j.ygyno.2016.11.002.","journal-title":"Gynecol Oncol."},{"key":"12353_CR22","unstructured":"U.S. Food and Drug Administration. Update: perform only contained morcellation when laparoscopic power morcellation is appropriate. FDA Safety Communication. Silver Spring, MD: FDA; 2020. Available at:\u00a0https:\/\/www.fda.gov\/medical-devices\/safety-communications\/update-perform-only-contained-morcellation-when-laparoscopic-power-morcellation-appropriate-fda."},{"key":"12353_CR23","doi-asserted-by":"publisher","unstructured":"American College of Obstetricians and Gynecologists\u2019 Committee on Gynecologic Practice. Uterine morcellation for presumed leiomyomas: ACOG Committee Opinion, Number 822. Obstet Gynecol. 2021;137(3):e63\u2013e74. https:\/\/doi.org\/10.1097\/AOG.0000000000004291","DOI":"10.1097\/AOG.0000000000004291"},{"key":"12353_CR24","doi-asserted-by":"publisher","first-page":"CD013352","DOI":"10.1002\/14651858.CD013352.pub2","volume":"5","author":"F Zullo","year":"2020","unstructured":"Zullo F, Venturella R, Raffone A, Saccone G. In-bag manual versus uncontained power morcellation for laparoscopic myomectomy. Cochrane Database Syst Rev. 2020;5:CD013352. https:\/\/doi.org\/10.1002\/14651858.CD013352.pub2.","journal-title":"Cochrane Database Syst Rev."},{"issue":"8","key":"12353_CR25","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.jogoh.2019.03.003","volume":"48","author":"V Karata\u015fl\u0131","year":"2019","unstructured":"Karata\u015fl\u0131 V, \u00c7ak\u0131r \u0130, Ayaz D, Budak A, Sanc\u0131 M. Clinicopathologic evaluation of uterine smooth muscle tumors of uncertain malignant potential (STUMP): a single center experience. J Gynecol Obstet Hum Reprod. 2019;48(8):637\u201342. https:\/\/doi.org\/10.1016\/j.jogoh.2019.03.003.","journal-title":"J Gynecol Obstet Hum Reprod."},{"issue":"5","key":"12353_CR26","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1097\/PAS.0b013e3182851162","volume":"37","author":"D Lim","year":"2013","unstructured":"Lim D, Alvarez T, Nucci MR, et al. Interobserver variability in the interpretation of tumor cell necrosis in uterine leiomyosarcoma. Am J Surg Pathol. 2013;37(5):650\u20138. https:\/\/doi.org\/10.1097\/PAS.0b013e3182851162.","journal-title":"Am J Surg Pathol."},{"issue":"Suppl 1","key":"12353_CR27","doi-asserted-by":"publisher","first-page":"S104","DOI":"10.1038\/modpathol.2015.139","volume":"29","author":"E Oliva","year":"2016","unstructured":"Oliva E. Practical issues in uterine pathology from banal to bewildering: the remarkable spectrum of smooth muscle neoplasia. Mod Pathol. 2016;29(Suppl 1):S104-120. https:\/\/doi.org\/10.1038\/modpathol.2015.139.","journal-title":"Mod Pathol."},{"key":"12353_CR28","first-page":"132A","volume":"14","author":"K Atkins","year":"2001","unstructured":"Atkins K, Bell S, Kempson R, et al. Epithelioid smooth muscle of the uterus. Mod Pathol. 2001;14:132A.","journal-title":"Mod Pathol."},{"issue":"1","key":"12353_CR29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/PAS.0000000000001083","volume":"43","author":"KA Devereaux","year":"2019","unstructured":"Devereaux KA, Kunder CA, Longacre TA. ALK-rearranged tumors are highly enriched in the STUMP subcategory of uterine tumors. Am J Surg Pathol. 2019;43(1):64\u201374. https:\/\/doi.org\/10.1097\/PAS.0000000000001083.","journal-title":"Am J Surg Pathol."},{"issue":"1","key":"12353_CR30","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1200\/JCO.1997.15.1.350","volume":"15","author":"L Guillou","year":"1997","unstructured":"Guillou L, Coindre JM, Bonichon F, et al. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol. 1997;15(1):350\u201362. https:\/\/doi.org\/10.1200\/JCO.1997.15.1.350.","journal-title":"J Clin Oncol."},{"issue":"22","key":"12353_CR31","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1093\/jnci\/djr393","volume":"103","author":"M Dowsett","year":"2011","unstructured":"Dowsett M, Nielsen TO, A\u2019Hern R, et al. Assessment of Ki67 in breast cancer: Recommendations from the International Ki67 in Breast Cancer Working Group. J Natl Cancer Inst. 2011;103(22):1656\u201364. https:\/\/doi.org\/10.1093\/jnci\/djr393.","journal-title":"J Natl Cancer Inst."},{"issue":"2","key":"12353_CR32","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s10549-016-3817-9","volume":"157","author":"S Bustreo","year":"2016","unstructured":"Bustreo S, Osella-Abate S, Cassoni P, et al. Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up. Breast Cancer Res Treat. 2016;157(2):363\u201371. https:\/\/doi.org\/10.1007\/s10549-016-3817-9.","journal-title":"Breast Cancer Res Treat."},{"issue":"3","key":"12353_CR33","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41416-019-0656-6","volume":"122","author":"E Vissio","year":"2020","unstructured":"Vissio E, Metovic J, Osella-Abate S, et al. Integration of Ki-67 index into AJCC 2018 staging provides additional prognostic information in breast tumours candidate for genomic profiling. Br J Cancer. 2020;122(3):382\u20137. https:\/\/doi.org\/10.1038\/s41416-019-0656-6.","journal-title":"Br J Cancer."},{"issue":"11","key":"12353_CR34","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1111\/j.0001-6349.2004.00502.x","volume":"83","author":"K Mayerhofer","year":"2004","unstructured":"Mayerhofer K, Lozanov P, Bodner K, Bodner-Adler B, Kimberger O, Czerwenka K. Ki-67 expression in patients with uterine leiomyomas, uterine smooth muscle tumors of uncertain malignant potential (STUMP) and uterine leiomyosarcomas (LMS). Acta Obstet Gynecol Scand. 2004;83(11):1085\u20138. https:\/\/doi.org\/10.1111\/j.0001-6349.2004.00502.x.","journal-title":"Acta Obstet Gynecol Scand."},{"key":"12353_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2021.153592","volume":"226","author":"A Travaglino","year":"2021","unstructured":"Travaglino A, Raffone A, Gencarelli A, et al. p53, p16 and ki67 as immunohistochemical prognostic markers in uterine smooth muscle tumors of uncertain malignant potential (STUMP). Pathol Res Pract. 2021;226:153592. https:\/\/doi.org\/10.1016\/j.prp.2021.153592.","journal-title":"Pathol Res Pract."},{"issue":"3","key":"12353_CR36","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.2018.19323","volume":"321","author":"AG Waks","year":"2019","unstructured":"Waks AG, Winer EP. Breast cancer treatment: a review. JAMA. 2019;321(3):288\u2013300. https:\/\/doi.org\/10.1001\/jama.2018.19323.","journal-title":"JAMA."},{"issue":"1","key":"12353_CR37","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/IGC.0b013e3182788466","volume":"23","author":"D Zhao","year":"2013","unstructured":"Zhao D, Zhang F, Zhang W, He J, Zhao Y, Sun J. Prognostic role of hormone receptors in ovarian cancer: a systematic review and meta-analysis. Int J Gynecol Cancer. 2013;23(1):25\u201333. https:\/\/doi.org\/10.1097\/IGC.0b013e3182788466.","journal-title":"Int J Gynecol Cancer."},{"issue":"4","key":"12353_CR38","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1093\/ajcp\/aqw030","volume":"145","author":"B Davidson","year":"2016","unstructured":"Davidson B, Kj\u00e6reng ML, F\u00f8rsund M, Danielsen HE, Kristensen GB, Abeler VM. Progesterone receptor expression is an independent prognosticator in FIGO Stage I uterine leiomyosarcoma. Am J Clin Pathol. 2016;145(4):449\u201358. https:\/\/doi.org\/10.1093\/ajcp\/aqw030.","journal-title":"Am J Clin Pathol."},{"issue":"3","key":"12353_CR39","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/PGP.0b013e31815ea7f5","volume":"27","author":"L Chen","year":"2008","unstructured":"Chen L, Yang B. Immunohistochemical analysis of p16, p53, and Ki-67 expression in uterine smooth muscle tumors. Int J Gynecol Pathol. 2008;27(3):326\u201332. https:\/\/doi.org\/10.1097\/PGP.0b013e31815ea7f5.","journal-title":"Int J Gynecol Pathol."},{"issue":"7","key":"12353_CR40","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/modpathol.2015.3","volume":"28","author":"S Croce","year":"2015","unstructured":"Croce S, Ribeiro A, Brulard C, et al. Uterine smooth muscle tumor analysis by comparative genomic hybridization: a useful diagnostic tool in challenging lesions. Mod Pathol. 2015;28(7):1001\u201310. https:\/\/doi.org\/10.1038\/modpathol.2015.3.","journal-title":"Mod Pathol."},{"issue":"5","key":"12353_CR41","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/modpathol.2017.185","volume":"31","author":"S Croce","year":"2018","unstructured":"Croce S, Ducoulombier A, Ribeiro A, et al. Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumors. Mod Pathol. 2018;31(5):816\u201328. https:\/\/doi.org\/10.1038\/modpathol.2017.185.","journal-title":"Mod Pathol."},{"issue":"4","key":"12353_CR42","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.3390\/ijms22041580","volume":"22","author":"D Conconi","year":"2021","unstructured":"Conconi D, Redaelli S, Lissoni AA, et al. Genomic and epigenomic profile of uterine smooth muscle tumors of uncertain malignant potential (STUMPs) revealed similarities and differences with leiomyomas and leiomyosarcomas. Int J Mol Sci. 2021;22(4):1580. https:\/\/doi.org\/10.3390\/ijms22041580.","journal-title":"Int J Mol Sci."},{"issue":"3","key":"12353_CR43","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.21873\/anticanres","volume":"40","author":"A Rizzo","year":"2020","unstructured":"Rizzo A, Ricci AD, Saponara M, et al. Recurrent uterine smooth-muscle tumors of uncertain malignant potential (STUMP): state of the art. Anticancer Res. 2020;40(3):1229\u201338. https:\/\/doi.org\/10.21873\/anticanres.","journal-title":"Anticancer Res."},{"issue":"3","key":"12353_CR44","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.ygyno.2018.09.010","volume":"151","author":"ME Roberts","year":"2018","unstructured":"Roberts ME, Aynardi JT, Chu CS. Uterine leiomyosarcoma: a review of the literature and update on management options. Gynecol Oncol. 2018;151(3):562\u201372. https:\/\/doi.org\/10.1016\/j.ygyno.2018.09.010.","journal-title":"Gynecol Oncol."}],"updated-by":[{"DOI":"10.1245\/s10434-022-12594-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T00:00:00Z","timestamp":1663718400000}}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12353-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-12353-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12353-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T21:18:41Z","timestamp":1676409521000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-12353-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,17]]},"references-count":44,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["12353"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-12353-y","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,17]]},"assertion":[{"value":"30 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1245\/s10434-022-12594-x","URL":"https:\/\/doi.org\/10.1245\/s10434-022-12594-x","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}